Table 6 Critical appraisal result of the studies using cohort study design

From: A systematic review to identify assessment instruments for social isolation or loneliness in adults with heart failure

Included articles

Criterion no. (items included to appraise cohort studies)

1

2

3

4

5

6

7

8

9

10

11

Total

Raw %

Risk

(Brouwers et al.61)

*

X

*

*

7

63.6

Moderate

(Cené et al.43)

*

10

90.9

Low

(Checa et al.51)

*

*

9

81.8

Low

(Cené et al.42)

*

10

90.9

Low

(Coyte et al.37)

11

100

Low

(Liang et al.18)

11

100

Low

(Manemann et al.47)

X

*

9

81.8

Low

(Murberg34)

X

*

*

8

72.7

Low

(Savitz et al.48)

*

*

8

81.8

Low

(Spaderna et al.35)

X

*

*

8

72.7

Low

(Sterling et al.36)

*

*

*

8

72.7

Low

(Yang et al.39)

X

10

90.9

Low

(Saito et al.41)

*

*

X

8

72.7

Low

(Keyes et al.49)

X

X

X

*

7

63.6

Moderate

(Löfvenmark et al.57)

*

*

9

81.8

Low

(Kitakata et al.40)

X

*

*

8

72.7

Low

(Yildirim et al.60)

*

X

*

*

7

63.6

Moderate

  1. √ = yes, X = no, * = unclear, ¥ = not applicable
  2. Criterion No. 1: Were the two groups similar and recruited from the same population? No. 2: Were the exposures measured similarly to assign people to both exposed and unexposed groups? No. 3: Was the exposure measured in a valid and reliable way? No. 4: Were confounding factors identified? No. 5: Were strategies to deal with confounding factors stated? No. 6: Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? No. 7: Were the outcomes measured in a valid and reliable way? No. 8: Was the follow up time reported and sufficient to be long enough for outcomes to occur? No 9: Was follow up complete, and if not, were the reasons to loss to follow up described and explored? No. 10: Were strategies to address incomplete follow up utilized? No. 11: Was appropriate statistical analysis used?